Navi Mumbai, India

Vs Prasada Rao Lingam

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vs Prasada Rao Lingam. Retrieved from https://idiyas.com/inventor/vs-prasada-rao-lingam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vs Prasada Rao Lingam: Innovator in Pharmaceutical Science

Introduction

Vs Prasada Rao Lingam is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that serve as dipeptidyl peptidase IV (DPP-IV) inhibitors. His work is crucial in the advancement of treatments for various medical conditions.

Latest Patents

Vs Prasada Rao Lingam holds a patent for "Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them." This invention relates to novel compounds that are useful as DPP-IV inhibitors, characterized by specific formulas where X, Y, a, R, and R are defined in the patent documentation. This patent highlights his innovative approach to drug development.

Career Highlights

He is currently associated with Glenmark Pharmaceuticals S.A., where he continues to contribute to the pharmaceutical industry. His expertise and dedication have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Vs Prasada Rao Lingam has collaborated with esteemed colleagues, including Abraham Thomas and Balasubramanian Gopalan. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Vs Prasada Rao Lingam exemplifies the spirit of innovation in the pharmaceutical sector. His contributions, particularly in the area of DPP-IV inhibitors, underscore the importance of research and development in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…